Global Presence
MSN Incorporation to API
Dr. MSN Reddy founded MSN Laboratories to produce high-quality pharmaceutical ingredients (APIs) in support of our partners.
1st DMF Filing
This milestone marks the beginning of our longstanding commitment to regulatory excellence, and our commitment to deliver quality products.
Established Formulations and First export
Dr. MSN Reddy launched our formulations division, enhancing our ability to deliver high-quality care to patients. This year also marked a key milestone with our first export, marking the start of our impact on global healthcare.
Established Asia’s Biggest R&D Center
MSN established Asia’s largest integrated R&D center, bringing formulation and API research together under one roof. A milestone that continues to power our purpose “Research for Better Medicine”
Established First Export Oriented Unit
This key step expanded our international reach, boosting our production and distribution capabilities to serve patients around the world.
Establishment of Vivanta generics as MSN’s subsidiary
Vivanta Generics, located in the UK, has significantly contributed to enhancing our capabilities in the generics market.
Establishment of first international manufacturing plant - New Jersey, USA
The manufacturing facility in New Jersey, USA, accelerated our ability to serve customers globally and expanded our production capacity.
No 1 in Active DMF filings in the world
Showcasing how far we have come since 2006, this accomplishment meant a great deal to all the people who have contributed to our commendable record in regulatory compliance.
Expanding to Injectables & Ophthalmics
This expansion to our portfolio increased our capacity to help patients in a variety of medical circumstances.
Launch of Biotech
This new division is dedicated to advancing research and development in biotechnology, focusing on creating cutting-edge therapies and solutions to address complex medical needs
